VEDL

VEDANTA: NUVAMA RAISES TARGET TO ₹806, MAINTAIN BUY Company is close to receiving statutory clearances for demerger into five separately listed entities, unlocking shareholder value. Strong commodity prices, cost reductions, and volume growth support the investment thesis. FY27E/28E EBITDA estimates raised 17%/8%, projecting a 20% CAGR over FY25–28E. Current price does not fully reflect value of aluminium and zinc businesses; remaining stakes effectively free.